How Much Did RapidPulse Raise?
Funding & Key Investors

RapidPulse has secured significant capital, with a total funding amount of $25.5M. The company recently announced a major strategic investment of $10.5M, underscoring its progress in the medical device sector. This latest financing round follows previous funding, indicating a consistent growth trajectory and investor confidence in RapidPulse's innovative approach to vascular products.

What is RapidPulse?

RapidPulse
ManufacturingMedical Devices & EquipmentBusiness Services

RapidPulse is a medical device development company specializing in the creation of minimally invasive vascular products designed for the treatment of ischemic stroke. Based in Miami, Florida, the company is focused on advancing therapeutic solutions within the critical field of neurovascular intervention. Their product development aims to address significant unmet needs in stroke care, positioning them as a key player in the MedTech industry.

How much funding has RapidPulse raised?

RapidPulse has raised a total of $25.5M across 2 funding rounds:

2021

Series A

$15M

2022

Other Financing Round

$10.5M

Series A (2021): $15M with participation from Sante Ventures, Hatteras Venture Partners, SYNTHEON Inc, Epidarex Capital, and Broadview Ventures

Other Financing Round (2022): $10.5M led by Hatteras Venture Partners, Santé Ventures, Epidarex Capital, Syntheon, and Broadview Ventures

Key Investors in RapidPulse

Hatteras Venture Partners

Hatteras Venture Partners is a venture capital firm focused on building transformative companies in the biotech, MedTech, and HealthTech sectors, investing in innovative healthcare solutions.

SYNTHEON Inc

Sync Medical is a company focused on next-generation medical innovations, offering a range of products across Cardiology, Vascular Access, Internal Medicine, and Joint Preservation.

Epidarex Capital

Epidarex is a transatlantic venture capital firm focused on building breakthrough life science companies in emerging hubs, utilizing deep scientific and industry networks.

What's next for RapidPulse?

The recent major strategic investment signals a pivotal phase for RapidPulse, likely enabling the company to accelerate product development, scale manufacturing capabilities, and expand its market reach. This infusion of capital is expected to support clinical trials, regulatory submissions, and commercialization efforts. The company's focus on minimally invasive vascular products for stroke treatment aligns with a growing demand for advanced neurovascular solutions, suggesting a strong potential for future growth and market penetration.

See full RapidPulse company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingPlastic, Packaging & ContainersLaw Firms & Legal Services
ManufacturingPulp & PaperPlastic, Packaging & Containers
Industrial Machinery & EquipmentManufacturing
Building MaterialsManufacturing

Frequently Asked Questions Regarding RapidPulse Financial Insights

What are the most recent funding rounds that RapidPulse has completed, and what were the funding rounds?
RapidPulse has recently completed 2 funding rounds: Other Financing Round on Sep 13, 2022, Series A on Jun 23, 2021.
What is the total amount of funding RapidPulse has raised to date?
RapidPulse has raised a total of $25.5M in funding to date.
How many funding rounds has RapidPulse completed?
RapidPulse has completed 2 funding rounds.
How much funding did RapidPulse raise in its most recent funding round?
RapidPulse raised $10.5M in its most recent funding round.
Who are the lead investors in RapidPulse's latest funding round?
The lead investor in RapidPulse's latest funding round was Hatteras Venture Partners. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in RapidPulse's history?
The largest funding round in RapidPulse's history was $15M.
See more information about RapidPulse